You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 166 No. 17, September 25, 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •CME Course for This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (28)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Aging/ Geriatrics
 •Cardiovascular Disease/ Myocardial Infarction
 •Treatment Adherence
 •Adherence
 •Alert me on articles by topic

Impact of Medication Therapy Discontinuation on Mortality After Myocardial Infarction

P. Michael Ho, MD, PhD; John A. Spertus, MD, MPH; Frederick A. Masoudi, MD, MSPH; Kimberly J. Reid, MS; Eric D. Peterson, MD, MPH; David J. Magid, MD, MPH; Harlan M. Krumholz, MD, SM; John S. Rumsfeld, MD, PhD

Arch Intern Med. 2006;166:1842-1847.

Background  Nonadherence to medications is common, but the determinants and consequences are poorly defined. The objectives of this study were to identify patient and myocardial infarction (MI) treatment factors associated with medication therapy discontinuation and to assess the impact of medication discontinuation 1 month after MI on 12-month mortality.

Methods  This was a multicenter prospective cohort of patients with MI enrolled in the Prospective Registry Evaluating Myocardial Infarction: Event and Recovery study. The outcomes were use of aspirin, beta-blockers, and statins at 1 month after MI hospitalization among patients discharged with all 3 medications as well as 12-month mortality.

Results  Of 1521 patients discharged with all 3 medications, 184 discontinued use of all 3 medications, 56 discontinued use of 2 medications, 272 discontinued use of 1 medication, and 1009 continued taking all 3 medications at 1 month. In multivariable analyses, patients not graduating from high school (odds ratio [OR], 1.76; 95% confidence interval [CI], 1.20-2.60) were more likely to discontinue use of all medications. The effect of increasing age on medication therapy discontinuation was greater for females (OR, 1.77; 95% CI, 1.34-2.34) than males (OR, 1.23; 95% CI, 1.02-1.47). Patients who discontinued use of all medications at 1 month had lower 1-year survival (88.5% vs 97.7%; log-rank P<.001) compared with patients who continued to take 1 or more medication(s). In multivariable survival analysis, medication therapy discontinuation was independently associated with higher mortality (hazards ratio, 3.81; 95% CI, 1.88-7.72). Results were consistent when evaluating discontinuation of use of aspirin, beta-blockers, and statins separately.

Conclusions  Medication therapy discontinuation after MI is common and occurs early after discharge. Patients who discontinue taking evidence-based medications are at increased mortality risk. These findings suggest the need to improve the transition of care from the hospital to outpatient setting to ensure that patients continue to take medications that have mortality benefit.


Author Affiliations: Denver Veterans Affairs Medical Center (Drs Ho and Rumsfeld), University of Colorado Health Sciences Center (Drs Ho, Masoudi, Magid, and Rumsfeld), Mid American Heart Institute (Dr Spertus and Ms Reid), and Denver Health Medical Center (Dr Masoudi), Denver, Colo; Duke Clinical Research Institute, Durham, NC (Dr Peterson); Clinical Research Unit, Kaiser Permanente of Colorado, Aurora (Dr Magid); and Yale University School of Medicine, New Haven, Conn (Drs Magid and Krumholz).


RELATED ARTICLES

Improving Medication Adherence: Challenges for Physicians, Payers, and Policy Makers
Patrick J. O’Connor
Arch Intern Med. 2006;166(17):1802-1804.
EXTRACT | FULL TEXT  

The Care Transitions Intervention: Results of a Randomized Controlled Trial
Eric A. Coleman, Carla Parry, Sandra Chalmers, and Sung-joon Min
Arch Intern Med. 2006;166(17):1822-1828.
ABSTRACT | FULL TEXT  

Cost-Related Medication Nonadherence Among Elderly and Disabled Medicare Beneficiaries: A National Survey 1 Year Before the Medicare Drug Benefit
Stephen B. Soumerai, Marsha Pierre-Jacques, Fang Zhang, Dennis Ross-Degnan, Alyce S. Adams, Jerry Gurwitz, Gerald Adler, and Dana Gelb Safran
Arch Intern Med. 2006;166(17):1829-1835.
ABSTRACT | FULL TEXT  

Effect of Medication Nonadherence on Hospitalization and Mortality Among Patients With Diabetes Mellitus
P. Michael Ho, John S. Rumsfeld, Frederick A. Masoudi, David L. McClure, Mary E. Plomondon, John F. Steiner, and David J. Magid
Arch Intern Med. 2006;166(17):1836-1841.
ABSTRACT | FULL TEXT  

Improved Therapeutic Monitoring With Several Interventions: A Randomized Trial
Adrianne C. Feldstein, David H. Smith, Nancy Perrin, Xiuhai Yang, Mary Rix, Marsha A. Raebel, David J. Magid, Steven R. Simon, and Stephen B. Soumerai
Arch Intern Med. 2006;166(17):1848-1854.
ABSTRACT | FULL TEXT  

Physician Communication When Prescribing New Medications
Derjung M. Tarn, John Heritage, Debora A. Paterniti, Ron D. Hays, Richard L. Kravitz, and Neil S. Wenger
Arch Intern Med. 2006;166(17):1855-1862.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Randomized Trial of Direct-to-Patient Communication to Enhance Adherence to {beta}-Blocker Therapy Following Myocardial Infarction
Smith et al.
Arch Intern Med 2008;168:477-483.
ABSTRACT | FULL TEXT  

The Year in Epidemiology, Health Services Research, and Outcomes Research
Krumholz and Masoudi
J Am Coll Cardiol 2007;50:2254-2262.
FULL TEXT  

Discontinuation of Statin Therapy and Clinical Outcome After Ischemic Stroke
Colivicchi et al.
Stroke 2007;38:2652-2657.
ABSTRACT | FULL TEXT  

Self-reported Medication Adherence and Cardiovascular Events in Patients With Stable Coronary Heart Disease: The Heart and Soul Study
Gehi et al.
Arch Intern Med 2007;167:1798-1803.
ABSTRACT | FULL TEXT  

Persistent Use of Evidence-Based Pharmacotherapy in Heart Failure Is Associated With Improved Outcomes
Gislason et al.
Circulation 2007;116:737-744.
ABSTRACT | FULL TEXT  

Update in Cardiology
Frye
ANN INTERN MED 2007;147:180-186.
FULL TEXT  

Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology
Authors/Task Force Members et al.
Eur Heart J 2007;28:1598-1660.
FULL TEXT  

Outcomes of Myocardial Infarction in Hospitals With Percutaneous Coronary Intervention Facilities
Labarere et al.
Arch Intern Med 2007;167:913-920.
ABSTRACT | FULL TEXT  

Performance Measures and Outcomes for Patients Hospitalized With Heart Failure
Shishehbor and Litaker
JAMA 2007;297:1547-1547.
FULL TEXT  

ADDITIONAL ARTICLES ABSTRACTED IN ACP JOURNAL CLUB
Evid. Based Med. 2007;12:62-62.
FULL TEXT  

JournalScan
Lindsay
Heart 2007;93:409-410.
FULL TEXT  

Relationship Between Adherence to Evidence-Based Pharmacotherapy and Long-term Mortality After Acute Myocardial Infarction
Rasmussen et al.
JAMA 2007;297:177-186.
ABSTRACT | FULL TEXT  

Poor adherence to drug treatment increases mortality after a heart attack
BMJ 2006;333:.
FULL TEXT  

A Wake-Up Call About Medication Nonadherence
Journal Watch Cardiology 2006;2006:3-3.
FULL TEXT  

Improving medication adherence: challenges for physicians, payers, and policy makers.
O'Connor
Arch Intern Med 2006;166:1802-1804.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.